XXXXEAS. Fuisz has over a period of years conducted research and development work and developed proprietary technology which is useful to make controlled-release formulations for pharmaceutical compounds and;
Appears in 4 contracts
Samples: Option/License Agreement (Kos Pharmaceuticals Inc), Option/License Agreement (Kos Pharmaceuticals Inc), Option/License Agreement (Kos Pharmaceuticals Inc)